fluvoxamine and Nervous-System-Diseases

fluvoxamine has been researched along with Nervous-System-Diseases* in 2 studies

Reviews

1 review(s) available for fluvoxamine and Nervous-System-Diseases

ArticleYear
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.
    Journal of medicinal chemistry, 2020, 12-24, Volume: 63, Issue:24

    The sigma-1 (σ

    Topics: Allosteric Regulation; Clinical Trials as Topic; Humans; Ligands; Nervous System Diseases; Piperidines; Receptors, sigma; Sigma-1 Receptor; Small Molecule Libraries

2020

Other Studies

1 other study(ies) available for fluvoxamine and Nervous-System-Diseases

ArticleYear
[Paroxysmal neurological manifestations disclosing panic attacks].
    Revue neurologique, 1992, Volume: 148, Issue:8-9

    Thirty-seven patients presented with paroxysmal neurological manifestations attributed to anxiety attacks. The manifestations included loss of consciousness, focal sensorimotor deficits, diffuse dysesthaesiae, visual disorders and tremor. They lasted 10 to 45 minutes and occurred once per day to once per week. Organic pathology was dismissed on the basis of normal examinations and atypical course. In all patients questioning revealed symptoms that were those of acute anxiety. The fact that these attacks took place in suggestive (circumstances e.g. in crowds and car driving), and that they could be induced by challenge tests hyperpnoea, infusion of lactate) suggested that these disorders were consecutive to panic attacks.

    Topics: Adult; Agoraphobia; Anti-Anxiety Agents; Benzodiazepines; Female; Fluvoxamine; Humans; Male; Middle Aged; Nervous System Diseases; Panic Disorder; Recurrence; Tremor; Vertigo

1992